Australia
# |
Name |
Net Income |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 2.64 B
|
June 30, 2024 | USD 173.13 | 0.11% |
|
Australia |
|
2 |
USD 180.96 M
|
June 30, 2024 | USD 20.43 | 1.47% |
|
Australia |
|
3 |
USD 76.50 M
|
June 30, 2024 | USD 21.11 | 1.40% |
|
Australia |
|
4 |
USD 55.20 M
|
June 30, 2024 | USD 157.25 | 0.24% |
|
Australia |
|
5 |
USD 23.76 M
|
June 30, 2024 | USD 7.32 | 6.16% |
|
Australia |
|
6 |
USD 15.96 M
|
June 30, 2024 | USD 2.14 | 0.82% |
|
Australia |
|
7 |
USD 3.55 M
|
Dec. 31, 2023 | USD 15.47 | 4.25% |
|
Australia |
|
8 |
USD 3.51 M
|
June 30, 2024 | USD 1.33 | 6.17% |
|
Australia |
|
9 |
USD 2.96 M
|
Jan. 31, 2024 | USD 1.81 | -0.44% |
|
Australia |
|
10 |
USD -3.20 M
|
Dec. 31, 2023 | USD 1.27 | -1.68% |
|
Australia |
|
11 |
USD -4.63 M
|
June 30, 2024 | USD 2.00 | 1.52% |
|
Australia |
|
12 |
USD -12.75 M
|
June 30, 2024 | USD 3.31 | -4.06% |
|
Australia |
|
13 |
USD -16.89 M
|
June 30, 2024 | USD 0.62 | -2.68% |
|
Australia |
|
14 |
USD -17.85 M
|
June 30, 2024 | USD 1.53 | 1.32% |
|
Australia |
|
15 |
USD -18.46 M
|
June 30, 2024 | USD 1.77 | -1.67% |
|
Australia |
|
16 |
USD -25.15 M
|
June 30, 2024 | USD 0.74 | -1.40% |
|
Australia |
|
17 |
USD -28.22 M
|
June 30, 2024 | USD 2.37 | 1.84% |
|
Australia |
|
18 |
USD -28.48 M
|
June 30, 2024 | USD 1.93 | -0.52% |
|
Australia |
|
19 |
USD -45.86 M
|
Dec. 31, 2023 | USD 5.88 | 0.14% |
|
Australia |
|
20 |
USD -87.96 M
|
June 30, 2024 | USD 1.58 | -2.06% |
|
Australia |
|
21 |
USD -116.17 M
|
June 30, 2024 | USD 2.80 | 2.04% |
|
Australia |
|
22 |
USD -220.24 M
|
June 30, 2024 | USD 3.82 | 6.70% |
|
Australia |
The Pharmaceuticals company in Australia with the highest Net Income is CSL Limited (ASX: CSL.AX) at USD 2.64 B.
The Pharmaceuticals company in Australia with the lowest Net Income is Opthea Limited (NasdaqGS: OPT) at USD -220.24 M.
The top 10 Pharmaceuticals companies in Australia by Net Income are CSL Limited, EBOS Group Limited, Ansell Limited, Pro Medicus Limited, Clinuvel Pharmaceuticals Limited, Australian Clinical Labs Limited, Telix Pharmaceuticals Limited, PolyNovo Limited, Sigma Healthcare Limited and Cyclopharm Limited.
The bottom 10 Pharmaceuticals companies in Australia by Net Income are Opthea Limited, Mayne Pharma Group Limited, Mesoblast Limited, Anteris Technologies Ltd, Immutep Limited, Clarity Pharmaceuticals Ltd, PYC Therapeutics Limited, Incannex Healthcare Limited, Kazia Therapeutics Limited and Trajan Group Holdings Limited.